Glaxo Relenza Program Will Address Diskhaler Ease of Use, Drug Efficacy
Executive Summary
Glaxo plans to monitor patient experience with its Relenza Diskhaler through an "active" Phase IV program for the inhaled antiviral influenza treatment. FDA approved Relenza July 27.
You may also be interested in...
WellPoint Hopes To Curb Relenza Costs By Pushing Flu Vaccination
WellPoint Health Networks is encouraging flu vaccinations in 280,000 letters to members, as part of a campaign to limit use of Glaxo Wellcome's influenza treatment Relenza.
WellPoint Hopes To Curb Relenza Costs By Pushing Flu Vaccination
WellPoint Health Networks is encouraging flu vaccinations in 280,000 letters to members, as part of a campaign to limit use of Glaxo Wellcome's influenza treatment Relenza.
Roche Tamiflu Prevents Flu In More Than 99% Of Frail Elderly - ICAAC
Prophylactic use of Roche's Tamiflu (oseltamivir) reduced the incidence of influenza in an elderly nursing home population to less than 1%, according to preliminary results from a once-daily prevention study presented by Frederick Hayden, MD, University of Virginia, Sept. 27 at the Interscience Conference on Antimicrobial Agents and Chemotherapy in San Francisco.